EyePoint Pharmaceuticals’s (PV3B) Moving Averages Convergence Divergence (MACD) indicator is -0.54, suggesting EyePoint Pharmaceuticals is a Sell.
EyePoint Pharmaceuticals’s (PV3B) 20-Day exponential moving average is 0.66, while EyePoint Pharmaceuticals’s (PV3B) share price is €0.28, making it a Sell.
EyePoint Pharmaceuticals’s (PV3B) 50-Day exponential moving average is 2.18, while EyePoint Pharmaceuticals’s (PV3B) share price is €0.28, making it a Sell.
EyePoint Pharmaceuticals’s (PV3B) 10-Day exponential moving average is 0.35, while EyePoint Pharmaceuticals’s (PV3B) share price is €0.28, making it a Sell.
EyePoint Pharmaceuticals’s (PV3B) 100-Day exponential moving average is 4.51, while EyePoint Pharmaceuticals’s (PV3B) share price is €0.28, making it a Sell.
EyePoint Pharmaceuticals’s (PV3B) stock price is €0.28 and EyePoint Pharmaceuticals’s (PV3B) 50-day simple moving average is 1.99, creating a Sell signal.
EyePoint Pharmaceuticals’s (PV3B) stock price is €0.28 and EyePoint Pharmaceuticals’s (PV3B) 100-day simple moving average is 5.58, creating a Sell signal.
EyePoint Pharmaceuticals’s (PV3B) stock price is €0.28 and EyePoint Pharmaceuticals’s (PV3B) 200-day simple moving average is 8.51, creating a Sell signal.